Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-03-26 Audit Report / Informat…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB NV - RC 31122020 - NL.pdf
Audit Report / Information Classification · 1% confidence The document is titled "Verslag van de commissaris aan de algemene vergadering van aandeelhouders over de jaarrekening voor het boekjaar afgesloten op 31 december 2020" (Report of the Commissioner to the General Meeting of Shareholders on the annual accounts for the financial year ended December 31, 2020). This document explicitly contains the auditor's opinion ('Oordeel zonder voorbehoud' - Unqualified opinion) on the annual financial statements ('jaarrekening'). This structure—a formal report from an external auditor/commissioner addressing the shareholders regarding the annual accounts—is characteristic of an Audit Report or Information filing, distinct from the full Annual Report (10-K) itself, although it is a key component of the annual reporting cycle. Given the specific focus on the audit opinion and the reference to the 'jaarrekening' (annual accounts), the most appropriate classification is 'AR' (Audit Report / Information). It is not the 10-K (the full annual report) nor is it a mere announcement of a report (RPA/RNS). FY 2020
2021-03-26 Dutch
Remuneration Policy 2021 Final post GNCC_TO BE PUBLISHED_EN.pdf
Remuneration Information Classification · 1% confidence The document is explicitly titled "UCB Remuneration Policy 2021". It details the philosophy, structure, and proposed changes for compensating Board members and Executive Committee members, referencing Belgian corporate law (BCCA) and the 2020 Code of Corporate Governance. This content directly addresses executive and director compensation, which aligns perfectly with the definition of Remuneration Information (DEF 14A), which covers compensation for top executives and directors. Although it mentions being submitted to the General Meeting of Shareholders, the document itself is the policy document, not the voting results (DVA) or the general AGM presentation (AGM-R). The length (35,185 chars) confirms it is a detailed report, not a short announcement (RPA/RNS).
2021-03-26 English
UCB SA_Board of Directors report_12_2020 FR Final.pdf
Management Reports Classification · 1% confidence The document is explicitly titled "Rapport annuel du Conseil d'Administration pour l'exercice social se clôturant le 31 décembre 2020" (Annual Report of the Board of Directors for the fiscal year ending December 31, 2020). It contains detailed financial results for the full year 2020, including a balance sheet, profit/loss analysis, and proposals for dividend allocation, which are hallmarks of a comprehensive annual financial report. Although it mentions referring to the 'Rapport annuel intégré 2020 du Groupe UCB' for consolidated results, this specific document details the statutory annual accounts and activities of the parent company UCB SA for the year, aligning perfectly with the definition of an Annual Report (10-K equivalent for non-US filers, or a comprehensive annual filing). The length (19,902 chars) confirms it is a full report, not just an announcement (RPA).
2021-03-26 French
Volmacht Algemene Vergadering 29 april 2021 - NL - Finaal.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled "VOLMACHT VOOR DE ALGEMENE VERGADERING VAN AANDEELHOUDERS VAN 29 APRIL 2021" (Proxy for the Annual General Meeting of Shareholders of April 29, 2021). It explicitly details the process for shareholders to grant proxy votes for the upcoming General Meeting, including agenda items such as the approval of the 2020 annual accounts, remuneration report, board appointments, and incentive plans. This document is a proxy form or related material used to solicit votes for an AGM, which aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). While it mentions AGM details, its primary function is soliciting votes via proxy, making PSI the most accurate fit over AGM-R (which is usually the presentation/minutes of the meeting itself).
2021-03-26 Dutch
UCB SA - RC 31122020 - ANG.pdf
Audit Report / Information Classification · 1% confidence The document is explicitly titled "Statutory auditor's report to the general shareholders' meeting on the annual accounts for the year ended 31 December 2020". It contains an "Unqualified opinion" on the annual accounts, details responsibilities under International Standards on Auditing (ISAs), discusses key audit matters, and addresses other legal and regulatory requirements related to the directors' report and social balance sheet. This content perfectly matches the definition of a standalone Audit Report / Information (AR), which covers audit results and applied accounting principles, distinct from the full Annual Report (10-K) or a mere announcement of a report (RPA). FY 2020
2021-03-26 English
Procuration Assemblée Générale 29 avril 2021 - FR - Finale.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 29 AVRIL 2021" (Proxy for the Shareholders' General Meeting of April 29, 2021). It contains instructions for shareholders on how to appoint a proxy to vote on various agenda items, including the approval of annual accounts, remuneration reports, director appointments/renewals, and approval of long-term incentive plans. This material is explicitly designed to solicit votes and provide information ahead of a General Meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it covers topics related to the AGM (AGM-R), the document's primary function is the proxy form itself.
2021-03-26 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.